Watch the webinar on Minimal Residual Disease (MRD) in myeloma and related diseases held by MPE
Myeloma Patients Europe (MPE) held a webinar Minimal Residual Disease (MRD) in myeloma and related diseases given by Paula van Hennik, Committee for Medicinal Products for Human Use (CHMP) member at the European Medicine Agency (EMA).